BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15322249)

  • 21. Evidence that TNF-TNFR1-TRADD-TRAF2-RIP-TAK1-IKK pathway mediates constitutive NF-kappaB activation and proliferation in human head and neck squamous cell carcinoma.
    Jackson-Bernitsas DG; Ichikawa H; Takada Y; Myers JN; Lin XL; Darnay BG; Chaturvedi MM; Aggarwal BB
    Oncogene; 2007 Mar; 26(10):1385-97. PubMed ID: 16953224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses.
    Ermolaeva MA; Michallet MC; Papadopoulou N; Utermöhlen O; Kranidioti K; Kollias G; Tschopp J; Pasparakis M
    Nat Immunol; 2008 Sep; 9(9):1037-46. PubMed ID: 18641654
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Keratin attenuates tumor necrosis factor-induced cytotoxicity through association with TRADD.
    Inada H; Izawa I; Nishizawa M; Fujita E; Kiyono T; Takahashi T; Momoi T; Inagaki M
    J Cell Biol; 2001 Oct; 155(3):415-26. PubMed ID: 11684708
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor necrosis factor-alpha induces early-onset endothelial adhesivity by protein kinase Czeta-dependent activation of intercellular adhesion molecule-1.
    Javaid K; Rahman A; Anwar KN; Frey RS; Minshall RD; Malik AB
    Circ Res; 2003 May; 92(10):1089-97. PubMed ID: 12714560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lycopene inhibits TNF-alpha-induced endothelial ICAM-1 expression and monocyte-endothelial adhesion.
    Hung CF; Huang TF; Chen BH; Shieh JM; Wu PH; Wu WB
    Eur J Pharmacol; 2008 May; 586(1-3):275-82. PubMed ID: 18439578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic effect of SCF and TNF-alpha on the up-regulation of cell-surface expression of ICAM-1 on human leukemic mast cell line (HMC)-1 cells.
    Tsang CM; Wong CK; Ip WK; Lam CW
    J Leukoc Biol; 2005 Jul; 78(1):239-47. PubMed ID: 15800027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of MAPK pathway in TNF-alpha-induced MMP-9 expression in human trophoblastic cells.
    Cohen M; Meisser A; Haenggeli L; Bischof P
    Mol Hum Reprod; 2006 Apr; 12(4):225-32. PubMed ID: 16520344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MAP kinase-dependent, NF-kappaB-independent regulation of inhibitor of apoptosis protein genes by TNF-alpha.
    Furusu A; Nakayama K; Xu Q; Konta T; Kitamura M
    J Cell Physiol; 2007 Mar; 210(3):703-10. PubMed ID: 17133355
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rosiglitazone attenuates NF-kappaB-dependent ICAM-1 and TNF-alpha production caused by homocysteine via inhibiting ERK1/2/p38MAPK activation.
    Bai YP; Liu YH; Chen J; Song T; You Y; Tang ZY; Li YJ; Zhang GG
    Biochem Biophys Res Commun; 2007 Aug; 360(1):20-6. PubMed ID: 17583675
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor necrosis factor-alpha induces MMP-9 expression via p42/p44 MAPK, JNK, and nuclear factor-kappaB in A549 cells.
    Lin CC; Tseng HW; Hsieh HL; Lee CW; Wu CY; Cheng CY; Yang CM
    Toxicol Appl Pharmacol; 2008 Jun; 229(3):386-98. PubMed ID: 18336852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular mechanisms for the release of chemokines from human leukemic mast cell line (HMC)-1 cells activated by SCF and TNF-alpha: roles of ERK, p38 MAPK, and NF-kappaB.
    Wong CK; Tsang CM; Ip WK; Lam CW
    Allergy; 2006 Mar; 61(3):289-97. PubMed ID: 16436136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of JNK and transcriptional repressor ATF3/LRF1 through the IRE1/TRAF2 pathway is implicated in human vascular endothelial cell death by homocysteine.
    Zhang C; Kawauchi J; Adachi MT; Hashimoto Y; Oshiro S; Aso T; Kitajima S
    Biochem Biophys Res Commun; 2001 Dec; 289(3):718-24. PubMed ID: 11726207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual role of TMS1/ASC in death receptor signaling.
    Parsons MJ; Vertino PM
    Oncogene; 2006 Nov; 25(52):6948-58. PubMed ID: 16715133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modified antisense oligonucleotides directed against tumor necrosis factor receptor type I inhibit tumor necrosis factor alpha-mediated functions.
    Ojwang JO; Mustain SD; Marshall HB; Rao TS; Chaudhary N; Walker DA; Hogan ME; Akiyama T; Revankar GR; Peyman A; Uhlmann E; Rando RF
    Biochemistry; 1997 May; 36(20):6033-45. PubMed ID: 9166774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of antisense IRAK-2 oligonucleotides on PGI2 release induced by IL-1 and TNF.
    Li YL; Guo FK; Wu SG
    Acta Pharmacol Sin; 2000 Jul; 21(7):646-8. PubMed ID: 11360675
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural determinants of DISC function: new insights into death receptor-mediated apoptosis signalling.
    Sessler T; Healy S; Samali A; Szegezdi E
    Pharmacol Ther; 2013 Nov; 140(2):186-99. PubMed ID: 23845861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor decreases thrombin receptor expression in endothelial cells.
    Yan W; Tiruppathi C; Qiao R; Lum H; Malik AB
    J Cell Physiol; 1996 Mar; 166(3):561-7. PubMed ID: 8600159
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TNF recruits TRADD to the plasma membrane but not the trans-Golgi network, the principal subcellular location of TNF-R1.
    Jones SJ; Ledgerwood EC; Prins JB; Galbraith J; Johnson DR; Pober JS; Bradley JR
    J Immunol; 1999 Jan; 162(2):1042-8. PubMed ID: 9916731
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effects of TNF-alpha or mmLDL on PAI-1 expression in human umbilical vein endothelial cells].
    Li XD; Zu SY; Zhu GJ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):156-9. PubMed ID: 12905793
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Agonist antibody activates death receptor 6 downstream signaling involving TRADD recruitment.
    Hu R; Du Q; Yin X; Li J; Wang T; Zhang L
    FEBS Lett; 2014 Jan; 588(3):401-7. PubMed ID: 24374337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.